Carolyn Chamberlain has been named Managing Director of Instar Europe. In this role, Carolyn’s focus will be directed on partnering with clients, exploring their business needs and providing them with a suite of innovative solutions powered by the most recent developments in primary MR to unlock commercial growth.

Carolyn brings 20+ years of experience in pharmaceutical market research to the team. Her career began at AstraZeneca where she led insights teams within CV and Oncology for over a decade. Her contributions helped drive the growth of blockbusters such as Crestor. Most recently, she held senior commercial positions with IPSOS, Kantar Health and the Adelphi Group, whilst also being a key contributor to EphMRA, PMRC and the BHBIA.   

"I’m thrilled to transition within the P\S\L family and join the dynamic Instar Europe team to help drive our growth agenda," Carolyn commented. "The inroads that Instar has made in leveraging primary MR with AI to help drive business insight has huge potential for our clients."

Jean-Olivier Marty, Group President Instar, said, "It is phenomenal news to have someone of Carolyn’s caliber and pedigree join the Instar team. Carolyn will be instrumental in further developing our successful relationships with Industry clients across Europe. Carolyn has a wealth of experience and expertise, which combined with her passion and dedication for solving clients business needs, makes her an ideal fit to help us continue our growth story."

P\S\L Group is a global organization dedicated to putting information at the service of medicine. It has offices in New York, Montreal, London, Kuala Lumpur, Querétaro, Cape Town and Luxembourg. Instar is a global primary market research business specialising in healthcare tracking and testing research that is focused on putting research at the heart of brand performance. It has developed truly innovative tracking & testing research products and leverages behavioural science, artificial intelligence and unparalleled fielding capabilities through LiMA (Leaders in Medicine Atlas), the wholly owned and largest directory of vetted, verified physicians in the world.